login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
RAPT THERAPEUTICS INC (RAPT) Stock News
USA
- NASDAQ:RAPT -
US75382E2081
-
Common Stock
30.21
USD
+0.51 (+1.72%)
Last: 10/31/2025, 8:09:40 PM
30.21
USD
0 (0%)
After Hours:
10/31/2025, 8:09:40 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
RAPT Latest News, Press Relases and Analysis
All
Press Releases
12 days ago - By: Chartmill
- Mentions:
XRTX
ADAP
FPAY
CELC
...
These stocks are moving in today's pre-market session
5 days ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Initiates prestIgE Phase 2b Clinical Trial of Ozureprubart (RPT904) in Patients with Food Allergies
10 days ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Announces Pricing of Public Offering of Common Stock
10 days ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Announces Pricing of Public Offering of Common Stock
11 days ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Announces Proposed Public Offering of Common Stock
11 days ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Announces Proposed Public Offering of Common Stock
12 days ago - By: Benzinga
- Mentions:
NBY
XRTX
REPL
ADAP
...
12 Health Care Stocks Moving In Monday's Intraday Session
12 days ago - By: Investor's Business Daily
- Mentions:
PFE
Rapt Therapeutics, Outperforming 98% Of All Stocks, Skyrockets After Topping Roche
12 days ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics and Shanghai Jeyou Pharmaceutical Announce Positive Topline Data from Phase 2 Trial of RPT904 (JYB1904) in Chronic Spontaneous Urticaria
12 days ago - By: Benzinga
- Mentions:
ADXN
OLMA
DCTH
RANI
...
Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
13 days ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 in Chronic Spontaneous Urticaria (CSU)
13 days ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 in Chronic Spontaneous Urticaria (CSU)
a month ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Announces FDA Clearance of IND Application to Proceed to Phase 2b Trial of RPT904 in Food Allergy
a month ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Announces FDA Clearance of IND Application to Proceed to Phase 2b Trial of RPT904 in Food Allergy
2 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
2 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
3 months ago - By: Zacks Investment Research
Wall Street Analysts Think Rapt Therapeutics (RAPT) Could Surge 101.02%: Read This Before Placing a Bet
3 months ago - By: Zacks Investment Research
Rapt Therapeutics (RAPT)'s Technical Outlook is Bright After Key Golden Cross
3 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Reports Second Quarter 2025 Financial Results
3 months ago - By: Zacks Investment Research
Wall Street Analysts Believe Rapt Therapeutics (RAPT) Could Rally 122.22%: Here's is How to Trade
4 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Names Two Industry Veterans to its Board of Directors
4 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Names Two Industry Veterans to its Board of Directors
5 months ago - By: Yahoo Finance
- Mentions:
FIS
JNVR
COIN
PSX
...
SOL Rebounds Toward $145 as 7 ETFs Advance and DeFi Dev Corp Eyes More SOL Purchases
5 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split
5 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split
5 months ago - By: Stocktwits
- Mentions:
NVS
UBS
Rapt Therapeutics Get A Bullish Recommendation On ‘Significant Opportunity’ For Allergy Drug Candidate: Retail Worries About Cash Position
5 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics to Participate in Upcoming Investor Conferences
5 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics to Participate in Upcoming Investor Conferences
6 months ago - By: Zacks Investment Research
Rapt Therapeutics (RAPT) Upgraded to Buy: Here's What You Should Know
6 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Reports First Quarter 2025 Financial Results
6 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Reports First Quarter 2025 Financial Results
7 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development
7 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development
8 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics to Participate in Upcoming Investor Conferences
Please enable JavaScript to continue using this application.